Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 4Colorectal Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 3Hematologic Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Obesity-Related Malignant Neoplasm 2Lymphoma 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Substance-Related Disorders 1Skin Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Opioid-Related Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Healthy Subject 1Genital Neoplasms, Female 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Neoplasms 1Diabetes Mellitus 1

Interventions

Ultrasonic Waves 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Substance-Related Disorders × Educational Status × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡